Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    Biothreat Antibiotic Susceptibility Testing with Biomerieux’s EasyMag

    By Global Biodefense StaffJuly 31, 2013
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick has issued a solicitation for Antibiotic Susceptibility Strips and EasyMag System Reagents that determine the quantitative antibiotic susceptibility of biothreat agents.

    Previously established USAMRIID protocols require bacterium be grown on agar plates in the presence of antibiotic e-strips coated with antibiotic gradients and marked with quantitative tick marks for measuring the zone of clearing.  This requirement is for brand name or equal EasyMag system reagents, consumables, controls, calibrators, and parts on an as-needed basis. 

    “The Biomerieux EasyMag is an automated nucleic acid extraction platform used by our division,” states the announcement. “The system is integrated into an ongoing funded study for both platform evaluation and support of mission essential sample processing.”

    The following are the Minimal Essential Characteristics for the EasyMag sample prep reagents to be procured:

    • Must be Biomerieux brand name or equivalent
    • Must be available for all 44 antibiotics requested
    • Must be packaged in 30 strip per package format
    • Must contain clearly labeled gradient tick marks of antibiotic concentration
    • Must provide 15 dilutions per strip
    • Must have antibiotic abbreviation written on top of Estrip
    • Must have expiration date no less than 1.5 years from time of order 

    Under the contract, USAMRIID places an order as required, and the vendor delivers as early as the next business day but no later than 5 business days. The Period of Performance is a twelve-month base year with four twelve-month options years. 

    Source: FBO.gov

    Editor’s Note: While the acquisition of laboratory equipment or reagents is commonplace, we periodically cover these activities for insight into the research, acquisition and mission priorities of biodefense-relevant organizations.

    Antimicrobials USAMRIID
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNew Modular Vaccine Design Combines Best of Existing Technologies
    Next Article University Research Spinoff Developing Handheld Malaria Diagnostic

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.